NOT-FD-21-003: Notice of Cancellation of the April 2021 Application Receipt Date for PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed"

Notice of Cancellation of the April 2021 Application Receipt Date for PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed"

Notice Number:

NOT-FD-21-003

Key Dates

Release Date:

January 12, 2021

Related Announcements

PAR-20-105 - Laboratory Flexible Funding Model (LFFM) (U19 Clinical Trials Not Allowed)

Issued by

U.S. Food and Drug Administration (FDA)

Purpose

The purpose of this Notice is to announce the cancellation of the April 6, 2021 application due date for PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19 Clinical Trials Not Allowed)". Applications will not be received or considered for the April 6, 2021 application due date.

Inquiries

Please direct all inquiries to:

Kiara Fowler

Grants Management Specialist

Office of Operations, Office of Finance Budget & Acquisitions

Office of Acquisitions and Grant Services, HFA-500

U.S. Food and Drug Administration

Tel: 240-402-3099

Kiara.Fowler@fda.hhs.gov